全文获取类型
收费全文 | 2231篇 |
免费 | 179篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 183篇 |
妇产科学 | 58篇 |
基础医学 | 187篇 |
口腔科学 | 95篇 |
临床医学 | 379篇 |
内科学 | 378篇 |
皮肤病学 | 50篇 |
神经病学 | 248篇 |
特种医学 | 153篇 |
外科学 | 219篇 |
综合类 | 33篇 |
一般理论 | 3篇 |
预防医学 | 236篇 |
眼科学 | 13篇 |
药学 | 82篇 |
肿瘤学 | 105篇 |
出版年
2021年 | 18篇 |
2020年 | 17篇 |
2019年 | 26篇 |
2018年 | 28篇 |
2017年 | 27篇 |
2016年 | 45篇 |
2015年 | 36篇 |
2014年 | 53篇 |
2013年 | 57篇 |
2012年 | 70篇 |
2011年 | 74篇 |
2010年 | 74篇 |
2009年 | 79篇 |
2008年 | 101篇 |
2007年 | 74篇 |
2006年 | 86篇 |
2005年 | 80篇 |
2004年 | 85篇 |
2003年 | 73篇 |
2002年 | 76篇 |
2001年 | 61篇 |
2000年 | 49篇 |
1999年 | 53篇 |
1998年 | 50篇 |
1997年 | 52篇 |
1996年 | 48篇 |
1995年 | 39篇 |
1994年 | 41篇 |
1993年 | 39篇 |
1992年 | 61篇 |
1991年 | 82篇 |
1990年 | 58篇 |
1989年 | 62篇 |
1988年 | 58篇 |
1987年 | 59篇 |
1986年 | 55篇 |
1985年 | 42篇 |
1984年 | 34篇 |
1983年 | 35篇 |
1982年 | 16篇 |
1981年 | 23篇 |
1980年 | 26篇 |
1979年 | 23篇 |
1978年 | 24篇 |
1977年 | 20篇 |
1976年 | 18篇 |
1975年 | 16篇 |
1974年 | 17篇 |
1973年 | 15篇 |
1972年 | 14篇 |
排序方式: 共有2424条查询结果,搜索用时 16 毫秒
61.
Tiffany Thomas Francesca Cendali Xiaoyun Fu Fabia Gamboni Evan J. Morrison Jonathan Beirne Travis Nemkov Marianna H. Antonelou Anastasios Kriebardis Ian Welsby Ariel Hay Karolina H. Dziewulska Michael P. Busch Steven Kleinman Paul W. Buehler Steven L. Spitalnik James C. Zimring Angelo D'Alessandro 《Transfusion》2021,61(6):1867-1883
62.
63.
K Ohi G Ursini M Li J H Shin T Ye Q Chen R Tao J E Kleinman T M Hyde R Hashimoto D R Weinberger 《Translational psychiatry》2015,5(4):e550
A genome-wide association study of cognitive deficits in patients with schizophrenia in Japan found association with a missense genetic variant (rs7157599, Asn8Ser) in the delta(4)-desaturase, sphingolipid 2 (DEGS2) gene. A replication analysis using Caucasian samples showed a directionally consistent trend for cognitive association of a proxy single-nucleotide polymorphism (SNP), rs3783332. Although the DEGS2 gene is expressed in human brain, it is unknown how DEGS2 expression varies during human life and whether it is affected by psychiatric disorders and genetic variants. To address these questions, we examined DEGS2 messenger RNA using next-generation sequencing in postmortem dorsolateral prefrontal cortical tissue from a total of 418 Caucasian samples including patients with schizophrenia, bipolar disorder and major depressive disorder. DEGS2 is expressed at very low levels prenatally and increases gradually from birth to adolescence and consistently expressed across adulthood. Rs3783332 genotype was significantly associated with the expression across all subjects (F3,348=10.79, P=1.12 × 10−3), particularly in control subjects (F1,87=13.14, P=4.86 × 10−4). Similar results were found with rs715799 genotype. The carriers of the risk-associated minor allele at both loci showed significantly lower expression compared with subjects homozygous for the non-risk major allele and this was a consistent finding across all diagnostic groups. DEGS2 expression showed no association with diagnostic status after correcting for multiple testing (P>0.05). Our findings demonstrate that a SNP showing genome-wide association study significant association with cognition in schizophrenia is also associated with regulation of DEGS2 expression, implicating a molecular mechanism for the clinical association. 相似文献
64.
G Jancso MT Jaberansari B Gasz Z Szanto B Cserepes E Rth 《Experimental & Clinical Cardiology》2004,9(1):21-25
OBJECTIVES:
To show that angiotensin-converting enzyme (ACE) inhibition potentiates subthreshold ischemic preconditioning (IPC) via the elevation of bradykinin activity, leading to a fully delayed cardioprotective response.METHODS:
On day 1 of the experiment, pigs were subjected to sham (group 1, controls) or IPC protocols. In groups 2 and 3, 4×5 min and 2×2 min of IPC, respectively, were elicited by occluding the left anterior descending coronary artery with percutaneous transluminal coronary angioplasty inflatable balloon catheter. Group 4 was subjected to the ACE inhibitor perindoprilate only. In group 5, the pigs were pretreated with perindoprilate (0.06 mg/kg) and then subjected to 2×2 min IPC. In group 6, intracoronary HOE 140 (a selective bradykinin B2 receptor antagonist) was added before the perindoprilateaugmented subthreshold (2×2 min) PC stimulus. On the second day, all animals underwent 40 min left anterior descending coronary artery ligation and 3 h reperfusion, followed by infarct size analysis using triphenyl tetrazolium chloride staining.RESULTS:
The rates of infarct size and risk zone were the following in the experimental groups: group 1, 42.8%; group 2,19.5% (P<0.05); group 3, ischemia/reperfusion (I/R) 33.4%; group 4, I/R 18.4% (P<0.05); group 5, I/R 31.2%; and group 6, I/R 36.3%. A significant increase of nuclear factor kappa B activation in groups 2 and 4 was seen.CONCLUSIONS:
Results confirm that ACE inhibitors do not give total pharmacological IPC, but they enhance the induction effect of small ischemic insults, which raises the ischemic tolerance of myocardium. It was determined that enhanced bradykinin activity leads to downstream nuclear factor kappa B activation in this model. 相似文献65.
Ganglioside inhibition of fibronectin-mediated cell adhesion to collagen. 总被引:42,自引:5,他引:42 下载免费PDF全文
H K Kleinman G R Martin P H Fishman 《Proceedings of the National Academy of Sciences of the United States of America》1979,76(7):3367-3371
Fibronectin mediates the adhesion of cells to collagen by first binding to the collagen substrate, followed by attachment of the cells to the fibronectin-collagen complex. Bovine brain gangliosides were found to block fibronectin-mediated cell adhesion to collagen in a concentration-dependent manner. The gangliosides did not block the binding of fibronectin to collagen but did prevent the attachment of the cells to the fibronectin-collagen complex. Of the individual gangliosides tested, GT1 and GD1a were the most effective inhibitors followed by GD1b greater than GM1 greater than GM2; GM3 was not an inhibitor. The inhibition of cell adhesion also was observed with the oligosaccharide portion of the gangliosides, but not with ceramides or with a variety of free sugars or glycosaminoglycans. Mild periodate oxidation of mixed gangliosides or of GD1a modified their sialic acid residues and the oxidized gangliosides were no longer inhibitory; subsequent reduction with NaBH4 did not restore the inhibitory activity of the modified gangliosides. These results suggest that specific gangliosides or related sialic acid-containing glycoconjugates on the cell surface may act as the receptors for fibronectin. 相似文献
66.
67.
68.
Busch MP; Laycock M; Kleinman SH; Wages JW Jr; Calabro M; Kaplan JE; Khabbaz RF; Hollingsworth CG 《Blood》1994,83(4):1143-1148
Blood donations in the United States have been screened for antibody to human T-lymphotropic virus type I (HTLV-I) by HTLV-I enzyme immunoassay (EIA) since November 1988. Specimens repeatedly found to be reactive by EIA undergo confirmation by supplementary serologic tests. We assessed the accuracy of blood center testing of 994 HTLV-I EIA repeat-reactive specimens in five US blood centers between November 1988 and December 1991. Of 410 confirmed HTLV-I/II donations, 407 (99.3%) were infected with HTLV-I/II, as determined by polymerase chain reaction (PCR) (403 cases) and by repeat serologic testing (4 cases). The three false- positive results occurred in the first year of testing. Of 425 HTLV- indeterminate specimens, 6 (1.4%) were found to be infected by PCR (5 with HTLV-II and 1 with HTLV-I). None of 159 confirmatory test-negative donations was PCR positive. Of HTLV-I/II-seropositive specimens, 80.2% to 95.4% could be typed as HTLV-I or HTLV-II by type-specific serologic assays. These results support recommendations that HTLV-I/II- seropositive donors should be advised that they are infected with HTLV- I, HTLV-II, or HTLV-I/II (depending on results of type-specific assays). HTLV-indeterminate donors should be advised that their results only rarely indicate HTLV infection. HTLV confirmatory test-negative donors should be reassured that they are not infected with HTLV-I or HTLV-II. 相似文献
69.
70.
Arthur Kleinman M.D 《Depression and anxiety》2013,30(6):503-505